Global Rabies Monoclonal Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Rabies Monoclonal Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Rabies monoclonal antibody (RMAb) is a type of antibody specifically targeted against the rabies virus, used for post-exposure prophylaxis.
Rabies Monoclonal Antibody report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Rabies Monoclonal Antibody market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Adult and Children are the major drivers for the industry.
The market for rabies monoclonal antibody is driven by its applications in rabies post-exposure treatment as part of rabies immunization protocols. RMAb is used in combination with the rabies vaccine to provide passive immunity against the virus. As rabies prevention and treatment continue to be essential public health measures, the market for rabies monoclonal antibody is expected to continue.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Rabies Monoclonal Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Serum Institute of India
NCPC
Crucell
Zydus
Synermore Biologics
Segment by Type
Category II Exposure
Category III Exposure
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rabies Monoclonal Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Rabies Monoclonal Antibody introduction, etc. Rabies Monoclonal Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Rabies Monoclonal Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Rabies Monoclonal Antibody report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Rabies Monoclonal Antibody market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Adult and Children are the major drivers for the industry.
The market for rabies monoclonal antibody is driven by its applications in rabies post-exposure treatment as part of rabies immunization protocols. RMAb is used in combination with the rabies vaccine to provide passive immunity against the virus. As rabies prevention and treatment continue to be essential public health measures, the market for rabies monoclonal antibody is expected to continue.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Rabies Monoclonal Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Serum Institute of India
NCPC
Crucell
Zydus
Synermore Biologics
Segment by Type
Category II Exposure
Category III Exposure
Segment by Application
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rabies Monoclonal Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Rabies Monoclonal Antibody introduction, etc. Rabies Monoclonal Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Rabies Monoclonal Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.